RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.

Source:http://linkedlifedata.com/resource/pubmed/id/14661056

Oncogene 2004 Feb 26 23 8 1539-48

Download in:

View as

General Info

PMID
14661056